文献速递区域麻醉与超声疼痛医学

静脉地塞米松不能延长腰大肌间隙阻滞:客观针刺感觉测试的前瞻性随机等效性试验

Intravenous dexamethasone fails to prolong psoas compartment block when assessed by objective pinprick sensory testing: a prospective, randomised, dose-dependent, placebo-controlled equivalency trial.
PubMed 文献 · Br J Anaesth · 2017-12-01

这项前瞻性随机安慰剂对照等效性试验纳入115例全髋关节置换术患者,比较静脉地塞米松4mg与8mg对腰大肌间隙阻滞时长的影响。以针刺感觉客观评估,两剂量组阻滞时长等效(18.5h vs 18.1h),但均未显著长于安慰剂(19.6h)。8mg组首次镇痛时间较安慰剂延长(533 vs 432min,P=0.047),但总阿片消耗无差异。

要点

  • 静脉地塞米松4mg与8mg对腰大肌间隙阻滞时长等效,均未较安慰剂显著延长阻滞。
  • 8mg组首次镇痛时间较安慰剂延长,但该差异在符合方案分析中未达显著性。
  • 各组术后疼痛评分及阿片类药物总消耗量无差异。

核心结论

  • 静脉地塞米松不能延长客观评估的腰大肌间隙阻滞时长,也不减少阿片总消耗。
  • 8mg地塞米松可延长首次镇痛时间,但该结果在符合方案分析中未达显著性。

研究设计与样本

  • 前瞻性、随机、安慰剂对照、剂量依赖、等效性试验,纳入115例全髋关节置换术患者。
  • 患者接受腰大肌间隙阻滞后分三组:安慰剂组15例、地塞米松4mg组50例、地塞米松8mg组50例。
  • 主要结局为经连续针刺评估的阻滞时长(小时),行意向治疗分析和符合方案分析。

主要发现

  • 意向治疗分析显示4mg与8mg组阻滞时长等效[均值(标准差)18.5h(8.0) vs 18.1h(7.1)]。
  • 4mg组与安慰剂组(19.6h(6.7))比较P=0.97,8mg组与安慰剂组比较P=0.77,均无差异。
  • 术后疼痛评分及阿片消耗各组无差异;8mg组首次镇痛时间较安慰剂延长(中位数533 vs 432min,P=0.047),符合方案分析P=0.058。

临床怎么用

  • 不应期望静脉地塞米松4mg或8mg能延长腰大肌间隙阻滞的客观感觉阻滞时长。
  • 若使用8mg地塞米松,或可延长首次镇痛时间,但证据在符合方案分析中不稳健。

局限性

  • 安慰剂组样本量(15例)明显小于地塞米松组(各50例)。
  • 8mg组首次镇痛时间优势在符合方案分析中未达显著性(P=0.058)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies have concluded that i.v. dexamethasone can prolong the duration of peripheral nerve blockade. We hypothesized that a 4 mg dose would equally prolong the duration of psoas compartment blocks (PCBs) when compared with 8 mg, and that both doses would prolong the duration when compared with placebo. METHODS: This was a prospective, randomized, placebo-controlled, dose-dependent, equivalency trial with 115 patients undergoing total hip arthroplasty. The patients received a PCB. Subsequently, 15 patients received i.v. normal saline (placebo), 50 patients received i.v. dexamethasone 4 mg, and 50 patients received i.v. dexamethasone 8 mg. The primary outcome was the duration in hours of PCB, determined by serial pinprick assessments. Secondary outcomes included pain scores, time to first analgesic, and opioid consumption. An intention-to-treat-analysis (ITA) and per-protocol analysis (PPA) were performed. RESULTS: The ITA showed that block duration in the 4 and 8 mg groups was equivalent [mean (standard deviation), 18.5 h (8.0) vs 18.1 h (7.1)]. However, neither group differed from placebo [19.6 h (6.7), (4 mg vs placebo), P=0.97; (8 mg vs placebo), P=0.77)]. Postoperative pain scores and opioid consumption were not different between groups. Time to first analgesic was not different between the 4 and 8 mg groups, or the 4 mg and placebo groups. The 8 mg group, however, had a longer time to first analgesic (median of 533 vs 432 min, P=0.047) when compared with placebo, although the significance was not observed in the PPA (P=0.058). CONCLUSIONS: I.V. dexamethasone did not prolong PCB when duration was objectively assessed, or decrease total opioid consumption. However, dexamethasone 8 mg prolonged the time to first analgesic. CLINICAL TRIAL REGISTRATION: NCT 02464176.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Turner JD, Dobson SW, Weller RS, et al. Intravenous dexamethasone fails to prolong psoas compartment block when assessed by objective pinprick sensory testing: a prospective, randomised, dose-dependent, placebo-controlled equivalency trial. Br J Anaesth. 2017. PMID: 29406180. doi:10.1016/j.bja.2017.11.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。